Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Alois Alzheimer (1864–1915) and the Alzheimer syndrome

View through CrossRef
Alois Alzheimer is known for his seminal work in recognizing a form of presenile dementia. His early interests were natural history and botany. He started his medical education in Berlin and attended the universities of Wurzburg and Tübingen. Nissl and Alzheimer worked together on extensive investigation of the pathology of the nervous system, especially the anatomy of the cerebral cortex. In 1902 Emil Kraepelin invited Alzheimer to work with him in the university psychiatric clinic in Heidelberg. In 1903 both moved to work in the university psychiatric clinic in Munich. It was during these years that Alzheimer described the Alzheimer's disease. He also described brain changes in arteriosclerosis, loss of nerve cells in Huntington's disease in the corpus striatum and brain changes in epilepsy. Alzheimer presented a preliminary report of his histological findings in 1906 at Tübingen about a 51-year-old lady who had developed presenile dementia and died within four years of onset of the disease. He published his findings in 1907, reporting the atrophic brain with neurofibrillary deposits and areas in the cerebrum resistant to staining. During the later years of his career Alzheimer concentrated on the study of changes in glial cells. His best-known works from this period were on Westphal-Strümpell pseudo-sclerosis of the brain, now assumed to be the same as Wilson's Disease. His death, at age 51, was the result of cardiac failure following endocarditis.
Title: Alois Alzheimer (1864–1915) and the Alzheimer syndrome
Description:
Alois Alzheimer is known for his seminal work in recognizing a form of presenile dementia.
His early interests were natural history and botany.
He started his medical education in Berlin and attended the universities of Wurzburg and Tübingen.
Nissl and Alzheimer worked together on extensive investigation of the pathology of the nervous system, especially the anatomy of the cerebral cortex.
In 1902 Emil Kraepelin invited Alzheimer to work with him in the university psychiatric clinic in Heidelberg.
In 1903 both moved to work in the university psychiatric clinic in Munich.
It was during these years that Alzheimer described the Alzheimer's disease.
He also described brain changes in arteriosclerosis, loss of nerve cells in Huntington's disease in the corpus striatum and brain changes in epilepsy.
Alzheimer presented a preliminary report of his histological findings in 1906 at Tübingen about a 51-year-old lady who had developed presenile dementia and died within four years of onset of the disease.
He published his findings in 1907, reporting the atrophic brain with neurofibrillary deposits and areas in the cerebrum resistant to staining.
During the later years of his career Alzheimer concentrated on the study of changes in glial cells.
His best-known works from this period were on Westphal-Strümpell pseudo-sclerosis of the brain, now assumed to be the same as Wilson's Disease.
His death, at age 51, was the result of cardiac failure following endocarditis.

Related Results

Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Abstract— Alzheimer's disease is a neurodegenerative disease that develops gradually, and is associated with cardiovascular and cerebrovascular problems. Alzheimer's is a serious d...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract Introduction Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
MicroRNA-1915-3p Promotes Cell Metastasis and Progression by Targeting Bcl2L11 in Hepatocellular Carcinoma
MicroRNA-1915-3p Promotes Cell Metastasis and Progression by Targeting Bcl2L11 in Hepatocellular Carcinoma
Abstract Background: Increasing evidence suggests that miR-1915-3p plays vital regulatory roles in metastasis and progression of several types of cancer. However, the roles...
microRNA-1915-3p Promotes Cell Metastasis and Progression by Targeting Bcl2L11 in Hepatocellular Carcinoma
microRNA-1915-3p Promotes Cell Metastasis and Progression by Targeting Bcl2L11 in Hepatocellular Carcinoma
Abstract BackgroundIncreasing evidence suggests that miR-1915-3p plays vital regulatory roles in metastasis and progression of several types of cancer. However, the roles a...
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
AbstractUnder the ATN framework, cerebrospinal fluid analytes provide evidence of the presence or absence of Alzheimer’s disease pathological hallmarks: amyloid plaques (A), phosph...
Determinants of Metabolic Syndrome among Malaysian Government Employees
Determinants of Metabolic Syndrome among Malaysian Government Employees
Introduction: The metabolic syndrome comprises a collection of cardiovascular disease risks, which has been demonstrated to predict type 2 diabetes mellitus and cardiovascular dise...
Down Syndrome
Down Syndrome
Abstract Down syndrome, first described by Langdon Down in 1866, is caused by an extra copy of all or part of chromosome 21. It is the most comm...

Back to Top